ArticleScientific reports2025
Adaptive average arterial pressure control by multi-agent on-policy reinforcement learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Modified Smith predictor-based fuzzy self-tuning FOPID controller for mean arterial pressure regulation.Scientific reports · 2026Article
- Experience-based integral reinforcement learning consensus for unknown multi-agent systems.Scientific reports · 2025Article
- The HM-TARGET personalised real-time haemodynamic targets in critical care.Nature communications · 2025Article
- Near real-time online reinforcement learning with synchronous or asynchronous updates.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current research introduces a model-free ultra-local model (MFULM) controller that utilizes the multi-agent on-policy reinforcement learning (MAOPRL) technique for remotely regulating blood pressure through precise drug dosing in a closed-loop system. Within the closed-loop system, there exists a MFULM controller, an observer, and an intelligent MAOPRL algorithm. Initially, a flexible MFULM controller is created to make adjustments to blood pressure and medication dosages. Following this, an observer is incorporated into the main controller to improve performance and stability by estimating states and disturbances. The controller parameters are optimized using MAOPRL in an adaptive manner, which involves the use of an actor-critic approach in an adaptive fashion. This approach enhances the adaptability of the controller by allowing for dynamic modifications to dosage and blood pressure control parameters. In the presence of disturbances or instabilities, the critic's feedback aids the actor in adjusting actions to reduce their impact, utilizing a complementary strategy to tackle deficiencies in the primary controller. Lastly, various evaluations, including assessments under normal conditions, adaptability between patients, and stability evaluations against mixed disturbances, have been carried out to confirm the efficiency and viability of the proposed method.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.